AXNX News and Press, Axonics Modulation Technologies Inc. From 05/08/20

Axonics Modulation Technologies (NASDAQ: AXNX ) prices public offering of 4M common shares at $32.50, yielding gross proceeds of ~$130M. More news on: Axonics Modulation Technologies, Inc., , Tech stocks news, Read more ...

Image source: The Motley Fool. Axonics Modulation Technlogs INC   (NASDAQ: AXNX) Q1 2020 Earnings Call May 05, 2020 , 4:30 p.m. ET Operator Continue reading

Gainers: MELI   +18.9% .   VAPO   +15.9% . CLW   +10.0% . NTNX   +10.0% . AXNX   +9.2% . More news on: MercadoLibre, Inc., Vapotherm, Inc., Clearwater Paper Corporation, Stocks on the move, , Read more ...

Axonics Modulation Technologies (NASDAQ: AXNX ): Q1 GAAP EPS of -$0.43 beats by $0.15 . More news on: Axonics Modulation Technologies, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, today reported financial results for the firs...

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, announced today the appointment of Michael H....

New Implantable Neurostimulator Decreases Recharge Interval to Only Once a Month Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (“SNM”) devices for the...

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, today announced that it will release financia...

Axonics Modulation Technologies (NASDAQ: AXNX ) submits a supplemental premarket approval (PMA) to the FDA to gain full-body magnetic resonance imaging (MRI) conditional labeling for 3.0T MRI scans. More news on: Axonics Modulation Technologies, Inc., Healthcare stocks news, Read mor...

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, today announced the submission of a premarket...